Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04548063 · ClinicalTrials.gov registry record · NA
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
A NA study of Cancer, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 266
- Enrollment target
- 1
- Study location
NCT04548063: Completed NA study of Cancer, sponsored by Mayo Clinic.
NCT04548063 is a NA study of Cancer that has completed, run by Mayo Clinic. The registered enrollment target is 266 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04548063, a NA study of Cancer, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 266 participants
- Enrollment target
- 1
- Study location
Study Summary
Researchers are using mock consent forms to see if wordiness has any effect on patients' understanding and willingness to sign up for a cancer clinical trial.
Primary Outcome
Number of participants to indicate on the self-reported patient questionnaire that the information provided in the consent form helped make a decision about whether or not to enroll in the trial. This is defined as a response of 1 or 2 on the Likert scale of 1=strongly agree and 5= strongly disagree for information in the consent form was helpful to the decision to join the study.
Conditions Studied
Interventions
- OTHER 6,000 word consent form
- OTHER 4,000 word consent form
- OTHER 2,000 word consent form
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 266 participants |
| Start Date | 2020-09-08 |
| Est. Completion | 2020-11-06 |
| Phase | NA |
What the finished NCT04548063 record still lists
NCT04548063 is an interventional study that assigns participants to a tested intervention. The registered 266 participants enrollment target is mid-sized for trials with a published cap, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 3 interventions - of which 6,000 word consent form is the first listed.
NCT04548063 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT04548063 about?
NCT04548063 is a clinical study titled "Consent Forms in Cancer Research: Examining the Effect of Length on Readability". Researchers are using mock consent forms to see if wordiness has any effect on patients' understanding and willingness to sign up for a cancer clinical trial.
What is the current status of trial NCT04548063?
This trial is currently completed. It is a NA study. The enrollment target is 266 participants. The study started on 2020-09-08. Estimated completion is 2020-11-06.
What conditions does trial NCT04548063 study?
This clinical trial studies the following conditions: Cancer.
What interventions are being tested in trial NCT04548063?
The interventions under investigation include: 6,000 word consent form (OTHER), 4,000 word consent form (OTHER), 2,000 word consent form (OTHER).
Who is sponsoring clinical trial NCT04548063?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04548063 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04548063's enrollment target sits among peer trials
266 198th of 615 higher than 418 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05098652 · 266 participants · NA
Coaching Dementia Caregivers to Master Care-Resistant Behavior
- NCT06088277 · 266 participants · NA
Texting to Reduce Human Immunodeficiency Virus (HIV) Risk
- NCT06261814 · 266 participants · Phase 2
Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors
- NCT06312124 · 266 participants · NA
A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI